UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 856

Sortiert nach

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Journal of Crohn's & colitis, 2014-06, Vol.8 (6), p.443-468

2014

Volltextzugriff (PDF)

Systematic review: macrophage activation syndrome in inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2013-06, Vol.37 (11), p.1033-1045

2013

Volltextzugriff (PDF)

Improving the Design of Undergraduate Biology Courses toward the Goal of Retention: The Case of Real-World Inquiry and Active Learning through Metagenomics

Journal of microbiology & biology education, 2020, Vol.21 (1)

2020

Volltextzugriff (PDF)

Mesalamine in the maintenance treatment of Crohn's disease: A meta-analysis adjusted for confounding variables

Gastroenterology (New York, N.Y. 1943), 1997-11, Vol.113 (5), p.1465-1473

1997

Volltextzugriff (PDF)

Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.1040-1041

2018

Volltextzugriff (PDF)

Reducing kidney motion: optimizing anesthesia and combining respiratory support for retrograde intrarenal surgery: a pilot study

BMC urology, 2019-07, Vol.19 (1), p.61-61, Article 61

2019

Volltextzugriff (PDF)

Preoperative radiotherapy for resectable rectal cancer: A meta-analysis

JAMA : the journal of the American Medical Association, 2000-08, Vol.284 (8), p.1008

2000

Volltextzugriff (PDF)

The Equitable Benefit Approach to guide the assessment of medical and psychosocial factors in liver transplant candidacy

Liver international, 2024-06

2024

Volltextzugriff (PDF)

Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis

The American journal of gastroenterology, 2001-03, Vol.96 (3), p.773-775

2001

Volltextzugriff (PDF)

Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo‐controlled trial with rifaximin

Alimentary pharmacology & therapeutics, 2006-04, Vol.23 (8), p.1117-1125

2006

Volltextzugriff (PDF)

Letter: should HCV cirrhotics with high bilirubin or Gilbert's syndrome be excluded from paritaprevir, ombitasvir, or dasabuvir?

Alimentary pharmacology & therapeutics, 2016-05, Vol.43 (9), p.1021-1022

2016

Volltextzugriff (PDF)

Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn’s colitis

The American journal of gastroenterology, 2001, Vol.96 (3), p.773-775

2001

Volltextzugriff (PDF)

Letter: a prospective real life comparison of the efficacy of adalimumab vs. golimumab in moderate to severe ulcerative colitis

Alimentary pharmacology & therapeutics, 2016-08, Vol.44 (3), p.310-311

2016

Volltextzugriff (PDF)

Clinical trial: ulcerative colitis maintenance treatment with 5‐ASA: a 1‐year, randomized multicentre study comparing MMX® with Asacol

Alimentary pharmacology & therapeutics, 2009-11, Vol.30 (9), p.908-918

2009

Volltextzugriff (PDF)

P.11.7: Prevalence and Incidence of Inflammatory Bowel Disease in two Italian Islands: A Study Based on Health Information Systems

Digestive and liver disease, 2017-03, Vol.49, p.e204-e205

2017

Volltextzugriff (PDF)

P.05.6: Epstein-Barr Virus Infection in Ulcerative Colitis and in Controls

Digestive and liver disease, 2017-03, Vol.49, p.e158-e158

2017

Volltextzugriff (PDF)

PC.1.7: BIOLOGIC THERAPIES VERSUS CONVENTIONAL THERAPIES. A SERIES OF CROHN'S DISEASE PATIENTS: “A PAIR-MATCHED STUDY”

Digestive and liver disease, 2011, Vol.43, p.S117-S117

2011

Volltextzugriff (PDF)

Letter: switching from one to another anti‐tumour necrosis factor alpha agent, and the risks of an overlap of exposure

Alimentary pharmacology & therapeutics, 2016-05, Vol.43 (9), p.1019-1020

2016

Volltextzugriff (PDF)

Infliximab and newly diagnosed neoplasia in Crohn’s disease: a multicentre matched pair study

Gut, 2006-02, Vol.55 (2), p.228-233

2006

Volltextzugriff (PDF)

Evaluating the apt epistemic processes of data literacy in elementary school students

Instructional science, 2023-02, Vol.51 (1), p.1-37

2023

Volltextzugriff (PDF)

OC.06.4: The Addition of an Immunosuppressant is an Effective Optimization Strategy after Loss of Response to Anti-Tnf Alpha Monotherapy in Patients with Inflammatory Bowel Disease: A Two-Year Experience

Digestive and liver disease, 2017-03, Vol.49, p.e92-e92

2017

Volltextzugriff (PDF)

OC.06.5: Mycophenolate Mofetil is a Valid Option in Patients with Inflammatory Bowel Disease Resistant to TNF-Alpha Inhibitors and Conventional Immunosuppressants

Digestive and liver disease, 2017-03, Vol.49, p.e92-e93

2017

Volltextzugriff (PDF)

P.11.3: Poor Tolerability Profile of Thiopurines in Inflammatory Bowel Disease: A Prospective Single-Centre Experience

Digestive and liver disease, 2017-03, Vol.49, p.e203-e203

2017

Volltextzugriff (PDF)

P.11.15: The Long Term Course of Patients Undergoing Ileal Pouch-Anal Anastomosis for Ulcerative Colitis

Digestive and liver disease, 2017-03, Vol.49, p.e208-e208

2017

Volltextzugriff (PDF)

Infliximab to treat Crohn's disease: an update

Clinical and experimental gastroenterology, 2011-01, Vol.4, p.227-238

2011

Volltextzugriff (PDF)

1 – 25 von 856

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(653)
Mit Volltextzugriff
(739)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(345)
Life Sciences & Biomedicine
(317)
Humans
(300)
Female
(200)
Male
(199)
Adult
(153)
Middle Aged
(140)
Biological And Medical Sciences
(117)
Medical Sciences
(107)
Gastroenterology & Hepatology
(75)
Aged
(70)
Animals
(49)
Adolescent
(43)
Gastroenterology And Hepatology
(42)
Gastroenterology. Liver. Pancreas. Abdomen
(41)
Risk Factors
(39)
Social Sciences
(35)
Quality Of Life
(34)
Other Diseases. Semiology
(31)
Pharmacology. Drug Treatments
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Systematic review: macrophage activation syndrome in inflammatory bowel disease

Improving the Design of Undergraduate Biology Courses toward the Goal of Retention: The Case of Real-World Inquiry and Active Learning through Metagenomics

Mesalamine in the maintenance treatment of Crohn's disease: A meta-analysis adjusted for confounding variables

Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab

Reducing kidney motion: optimizing anesthesia and combining respiratory support for retrograde intrarenal surgery: a pilot study

Preoperative radiotherapy for resectable rectal cancer: A meta-analysis

The Equitable Benefit Approach to guide the assessment of medical and psychosocial factors in liver transplant candidacy

Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis

Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo‐controlled trial with rifaximin

Letter: should HCV cirrhotics with high bilirubin or Gilbert's syndrome be excluded from paritaprevir, ombitasvir, or dasabuvir?

Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn’s colitis

Letter: a prospective real life comparison of the efficacy of adalimumab vs. golimumab in moderate to severe ulcerative colitis

Clinical trial: ulcerative colitis maintenance treatment with 5‐ASA: a 1‐year, randomized multicentre study comparing MMX® with Asacol

P.11.7: Prevalence and Incidence of Inflammatory Bowel Disease in two Italian Islands: A Study Based on Health Information Systems

P.05.6: Epstein-Barr Virus Infection in Ulcerative Colitis and in Controls

PC.1.7: BIOLOGIC THERAPIES VERSUS CONVENTIONAL THERAPIES. A SERIES OF CROHN'S DISEASE PATIENTS: “A PAIR-MATCHED STUDY”

Letter: switching from one to another anti‐tumour necrosis factor alpha agent, and the risks of an overlap of exposure

Infliximab and newly diagnosed neoplasia in Crohn’s disease: a multicentre matched pair study

Evaluating the apt epistemic processes of data literacy in elementary school students

OC.06.4: The Addition of an Immunosuppressant is an Effective Optimization Strategy after Loss of Response to Anti-Tnf Alpha Monotherapy in Patients with Inflammatory Bowel Disease: A Two-Year Experience

OC.06.5: Mycophenolate Mofetil is a Valid Option in Patients with Inflammatory Bowel Disease Resistant to TNF-Alpha Inhibitors and Conventional Immunosuppressants

P.11.3: Poor Tolerability Profile of Thiopurines in Inflammatory Bowel Disease: A Prospective Single-Centre Experience

P.11.15: The Long Term Course of Patients Undergoing Ileal Pouch-Anal Anastomosis for Ulcerative Colitis

Infliximab to treat Crohn's disease: an update

Suchergebnisse filtern